Category: Getinge AB
Here's a look at some of the top Wall Street stories for medical device companies this week.
Biomet is planning to put itself back on the public market after a 7-year run under private equity ownership, the orthopedics giant said today.
, Goldman Sachs
, Kohlberg Kravis Roberts & Co. L.P.
, Semler Scientific
, Terumo Corp.
, The Blackstone Group LP
, TPG Capital
, Analogic Corp.
, Fresenius Medical Care
, GE Healthcare
, Getinge AB
QMed releases a list of the 5 worst-performing medical device companies of early 2014, including Siemens, GE and Fresenius, among others.
MASSDEVICE ON CALL — Medtech giants have seen Wall Street bumps so far this year, but several of the company's in the industry's top 40 haven't been so fortunate.
Medical Device company Kinetic Concepts divests unit which makes therapeutic beds, mattress replacement systems and other support surfaces to Getinge for $275 million.
Kinetic Concepts is selling its Therapeutic Support Systems business to Getinge AB for $275 million, as the company looks to focus on its core wound care business.
3M's 4th-quarter profits beat The Street as it affirms its 2012 guidance, but shares stay flat; also, Hill-Rom's Q1 earnings slide 7%; Getinge sees 2011 profits rise 11% despite sales slide; ResMed's Q2 sales, earnings rise; Uroplasty pares Q3 losses on doubled sales; Encision swings to Q3 losses; and EnteroMedics' Q4, 2011 losses rise.
3M Co. (NYSE:MMM) beat expectations for its 4th-quarter profits and affirmed its guidance for 2012, but Wall Street remained unmoved, with shares staying flat in this morning's trading.
Getinge Group subsidiary Maquet restructures its U.S. sales and services organization to meet the growing hybrid operating room market.
Getinge Group subsidiary Maquet restructured the organization of its U.S. sales and services to meet the growing hybrid operating room market.
Hybrid OR's contain both a traditional operating room and a cardiac catheterization lab, minimizing the need to move a sick patient from room to room for complex procedures.
The suites are designed to foster collaboration between cardiologists, cardiac surgeons, interventional radiologists and vascular surgeons and build a more efficient workflow.
Johnson & Johnson's Ethicon Endo-Surgery completes its acquisition of medical device reprocessor SterilMed.
Johnson & Johnson's (NYSE:JNJ) Ethicon Endo-Surgery division finished its acquisition of Minnesota-based medical device reprocessor SterilMed Inc for an undisclosed amount.
SterilMed reprocesses medical devices and provides equipment repair and pre-owned equipment sales services. Johnson & Johnson said it plans to keep the SterilMed brand running as it integrates the business into the EES segment.
Baxter International raised the lower end of its full-year earnings forecast after posting strong third-quarter results; also, Danaher's profits slide despite strong sales; ICU Medical's Q3 sales stay flat, profits tick up; Getinge posts a profit but top line declines; Kensey Nash's Q1 2012 profits plunge; and Utah Medical's Q3 sales, earnings soar.
Baxter International Inc. (NYSE:BAX) said it now expects to post earnings of at least $4.29 per share this year, after logging strong third-quarter results.